# Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome

> **NCT04842448** · PHASE2 · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 80 (actual)

## Conditions studied

- COVID-19
- Post COVID-19 Condition
- Post COVID-19 Condition, Unspecified
- Post COVID Condition
- Post-COVID Syndrome
- Post-Acute COVID-19 Syndrome

## Interventions

- **DRUG:** Hyperbaric oxygen
- **PROCEDURE:** Sham treatment

## Key facts

- **NCT ID:** NCT04842448
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-15
- **Primary completion:** 2023-09-27
- **Final completion:** 2024-06-17
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04842448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04842448, "Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04842448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*